GPBAR1 and colitis: Finally, we have discovered that ciprofloxacin, a widely used antibiotic, is a GP-BAR1 agonist and that activation of GP-BAR1 with this agent or oleanolic acid, a natural GP-BAR1 ligand, attenuates colon inflammation in rodent models of colitis.